Loading...
Serum — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Serum
2025-Q4
Comprehensive analysis of India’s serum export trade — suppliers, buyers, prices, routes, and every shipment record.
171
Shipments
$9K
Trade Value
20
Suppliers
26
Buyers
6
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/serum
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s serum trade — 2025-Q4
KEY TAKEAWAY
Serum 2025-Q4 exports total $8.7K across 6 countries, with HIMEDIA LABORATORIES PVT LTD commanding 87.4% market share.
TOTAL SHIPMENTS
171
2025-Q4
EXPORT VALUE
$8.7K
FOB USD
TOTAL QUANTITY
3,511.5
units shipped
INDIAN SUPPLIERS
20
unique exporters
GLOBAL BUYERS
26
unique importers
DESTINATIONS
6
countries
MEDIAN UNIT PRICE
$0.474
per unit
TOP-5 SHARE
97.2%
of total USD
BRANDED SHARE
17.0%
29 shipments
DOSAGE FORMS
8
product types
6 KEY FINDINGS
1
HIMEDIA LABORATORIES PVT LTD is India's #1 Serum exporter with $7.6K (87.4% market share).→ §5, Indian Supplier Rankings
2
Serum reached 6 countries, with Nepal as the top destination ($7.6K).→ §4, Global Destination Map
3
Market concentration is high (HHI: 7671) — top 10 suppliers control 98.8% of exports.→ §5, Indian Supplier Rankings
4
73.1% of buyers (19 of 26) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Solution dominates (6.3%) across 8 dosage forms.→ §7, Price Benchmarks
6
4 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 HIMEDIA LABORATORIES PVT LTD leads in volume — how do 20 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian serum exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Serum report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial serum trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian serum suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Serum India trade report
Product scope
Serum
All variants merged — branded and generic formulations of serum
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
171
Every commercial serum trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a steady rise: Oct $0, Nov $820, Dec $7.8K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$0
Oct USD
0 shipments
2
$820
Nov USD
0.0% MoM
3
$7.8K
Dec USD
+857.1% MoM
4
Steady rise
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 0.0% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $0, making it the weakest month by value.
Fig 3.2 Q4 cumulative USD reached $9K.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $820 rise in Nov, $7K recovery in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $0 | 0 shipments |
| Nov | $820 | 105 shipments |
| Dec | $8K | 66 shipments |
| Q4 Total | $9K | 171 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 6 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Nepal held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: NOVO NORDISK INDIA PVT LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import serum from India, how much they buy, and who supplies each market
KEY TAKEAWAY
Nepal absorbs 87.4% of India’s 2025-Q4 serum trade ($7.6K). Beyond the top 6 destinations, 4 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Asia has 3 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 4 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much serum India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$8K
94.8% of trade
3 countries · 92 shipments
Europe
$148
1.7% of trade
2 countries · 26 shipments
Americas
$304
3.5% of trade
1 countries · 53 shipments
Fig 4.1 Nepal is the #1 corridor ($8K) — 6 flow arcs from India radiate across 3 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian serum it receives (light = low, dark = high). Orange arcs radiate from India to the top 6 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 6 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Nepal | $8K | 1 | HIMEDIA LABORATORIES PVT LTD | $8K | — | — | — | — |
| 2 | Singapore | $382 | 90 | NOVO NORDISK INDIA PVT LTD | $93 | NOVARTIS HEALTHCARE PVT LTD | $62 | WORLDWIDE CLINICAL TRIALS INDIA PVT LTD | $35 |
| 3 | United States | $304 | 53 | NOVARTIS HEALTHCARE PVT LTD | $114 | NOVO NORDISK INDIA PVT LTD | $102 | BRISTOL-MYERS SQUIBB INDIA PVT LTD | $57 |
| 4 | China | $255 | 1 | TCG LIFESCIENCES PVT LTD | $255 | — | — | — | — |
| 5 | United Kingdom | $142 | 25 | NOVO NORDISK INDIA PVT LTD | $68 | NOVARTIS HEALTHCARE PVT LTD | $63 | GLAXOSMITHKLINE PHARMACEUTICALS LTD | $6 |
| 6 | Netherlands | $6 | 1 | NOVARTIS HEALTHCARE PVT LTD | $6 | — | — | — | — |
Table 4.1 — Top 6 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 94.8% of USD — but Nepal is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
87.4%
#1 country share
Nepal alone
99.9%
Top 5 share
5 of 6 countries
100.0%
Top 15 share
Long tail of -9 countries = 0.0%
HHI 7687
Destination HHI
Highly concentrated
6
Countries served
Global pharma reach from India
3
Asia countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
20 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
HIMEDIA LABORATORIES PVT LTD ($7.6K, 87.4% share) and NOVO NORDISK INDIA PVT LTD ($264) together control 90.5% of India’s 2025-Q4 serum trade. The top 5 suppliers hold 97.2%. 20 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian serum suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 HIMEDIA LABORATORIES PVT LTD leads by $7K over NOVO NORDISK INDIA PVT LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: HIMEDIA LABORATORIES PVT is #1 by value but #16 by volume.
Fig 5.2 NOVO NORDISK INDIA PVT LTD also leads by shipment count (48) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: HIMEDIA LABORATORIES PVT moves from #16 by volume to #1 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 20 serum suppliers split into strategic segments
KEY TAKEAWAY
5 suppliers (25%) generate 97.2% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 HIMEDIA LABORATORIES PVT LTD and NOVO NORDISK INDIA PVT LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 97.2% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | NOVO NORDISK INDIA PVT LTD | 4 | 3 | $264 |
| 2 | NOVARTIS HEALTHCARE PVT LTD | 4 | 4 | $244 |
| 3 | BRISTOL-MYERS SQUIBB INDIA PVT LTD | 4 | 2 | $81 |
| 4 | JOHNSON & JOHNSON PVT LTD | 3 | 1 | $24 |
| 5 | PFIZER LTD | 3 | 1 | $12 |
| 6 | WORLDWIDE CLINICAL TRIALS INDIA PVT LTD | 2 | 1 | $35 |
| 7 | IQVIA RDS (INDIA) PVT LTD | 2 | 2 | $25 |
| 8 | KLINERA GLOBAL SERVICES | 2 | 1 | $24 |
| 9 | PAREXEL INTERNATIONAL CLINICAL RESEARCH PRIVATE LI | 2 | 1 | $10 |
| 10 | MEDPACE CLINICAL RESEARCH INDIA PVT LTD | 2 | 1 | $10 |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the serum manufacturing hubs
KEY TAKEAWAY
Thane and Mumbai together account for $8K of India’s 2025-Q4 serum trade.
Fig 5.5 Thane (1 exporters, $8K) and Mumbai (8 exporters, $389) are India’s serum capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
97.2%
Top 5 share
5 of 20 suppliers
98.8%
Top 10 share
10 of 20 suppliers
97.2%
Top 25% share
5 suppliers = 97% USD
HHI 7671
Supplier HHI
Concentrated
20
Total suppliers
shipped Serum in 2025-Q4
20+ cities
Indian hubs
Thane and Mumbai lead
§5.2 Coming next: 4 exporter deep-dive profiles
Each of the top 4 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | NOVO NORDISK INDIA PVT LTD | $264 |
| #2 | NOVARTIS HEALTHCARE PVT LTD | $244 |
| #3 | BRISTOL-MYERS SQUIBB INDIA PVT LTD | $81 |
| #4 | IQVIA RDS (INDIA) PVT LTD | $25 |
#2
EXPORTER PROFILE #1 OF 4
NOVO NORDISK INDIA PVT LTD
Bangalore · India’s #2 serum supplier by USD · 2025-Q4
2025-Q4 USD
$264
3.0% market share
SHIPMENTS
48
avg $5/ship
COUNTRIES
3
destination markets
BUYERS
9
5 single-sourced
BRANDED
25%
of shipments
DOSAGE FORMS
4
product types
TOP 3 DESTINATIONS
United States is the #1 market at $102 (39% of trade), followed by Singapore at $93. 3 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | United States | $102 | 18 | 38.8% |
| 2 | Singapore | $93 | 18 | 35.3% |
| 3 | United Kingdom | $68 | 12 | 25.9% |
MONTHLY TREND
Nov peaked at $159. Oct was the weakest at $0.
PRODUCT MIX
Solution dominates at 36% of trade. Other (25.1%) and Unknown are secondary formulations.
TOP BUYERS · 5/8 LOCKED IN
5 of 8 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Q SQUARED SOLUTIONS LTD | United States | $68 | ⚠ Locked |
| ICON LABORATORIES SING… | Singapore | $59 | ⚠ Locked |
| IQVIA LABORATORIES LTD | United Kingdom | $40 | ⚠ Locked |
| QUINTILES LABORATORIES… | United Kingdom | $28 | 3 sup. |
| IQVIA LABORATORIES LLC | United States | $23 | ⚠ Locked |
| Undisclosed buyer | Singapore | $21 | N/A |
| IQVIA LABORATORIES ASI… | Singapore | $11 | 4 sup. |
| LABCORP DEVELOPMENT (A… | Singapore | $8 | 7 sup. |
| CHARLES RIVER LABORATO… | United States | $6 | ⚠ Locked |
#2
EXPORTER PROFILE #1 OF 4 — TRADE FLOW MAP
NOVO NORDISK INDIA PVT LTD — Supplier → Country → Importer
3 destination countries, top 5 importers per country
Fig 5.P1.3 United States absorbs $102 — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 4 importers per destination.
#4
EXPORTER PROFILE #2 OF 4
NOVARTIS HEALTHCARE PVT LTD
Mumbai · India’s #4 serum supplier by USD · 2025-Q4
2025-Q4 USD
$244
2.8% market share
SHIPMENTS
46
avg $5/ship
COUNTRIES
4
destination markets
BUYERS
10
5 single-sourced
BRANDED
20%
of shipments
DOSAGE FORMS
4
product types
TOP 4 DESTINATIONS
United States is the #1 market at $114 (47% of trade), followed by United Kingdom at $63. 4 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | United States | $114 | 20 | 46.6% |
| 2 | United Kingdom | $63 | 11 | 25.6% |
| 3 | Singapore | $62 | 14 | 25.4% |
| 4 | Netherlands | $6 | 1 | 2.3% |
MONTHLY TREND
Nov peaked at $176. Oct was the weakest at $0.
PRODUCT MIX
Unknown dominates at 36% of trade. Solution (34.3%) and Other are secondary formulations.
TOP BUYERS · 5/9 LOCKED IN
5 of 9 buyers source exclusively from this supplier — moderate lock-in, some buyers diversify.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Q SQUARED SOLUTIONS LLC | United States | $102 | ⚠ Locked |
| QUINTILES LABORATORIES… | United Kingdom | $51 | 3 sup. |
| IQVIA LABORATORIES ASI… | Singapore | $24 | 4 sup. |
| Undisclosed buyer | Singapore | $20 | N/A |
| MEDPACE SINGAPORE PTE … | Singapore | $14 | 4 sup. |
| LABCORP DEVELOPMENT (A… | Singapore | $10 | 7 sup. |
| LABCORP EARLY DEVELOPM… | United Kingdom | $6 | ⚠ Locked |
| MOLECULAR MD | United States | $6 | ⚠ Locked |
| EUROFINS CENTRAL LABOR… | Netherlands | $6 | ⚠ Locked |
| Q SQUARED SOLUTIONS PT… | Singapore | $5 | ⚠ Locked |
#4
EXPORTER PROFILE #2 OF 4 — TRADE FLOW MAP
NOVARTIS HEALTHCARE PVT LTD — Supplier → Country → Importer
4 destination countries, top 5 importers per country
Fig 5.P2.3 United States absorbs $114 — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 5 importers per destination.
#5
EXPORTER PROFILE #3 OF 4
BRISTOL-MYERS SQUIBB INDIA PVT LTD
Mumbai · India’s #5 serum supplier by USD · 2025-Q4
2025-Q4 USD
$81
0.9% market share
SHIPMENTS
17
avg $5/ship
COUNTRIES
2
destination markets
BUYERS
4
2 single-sourced
BRANDED
12%
of shipments
DOSAGE FORMS
4
product types
TOP 2 DESTINATIONS
United States is the #1 market at $57 (70% of trade), followed by Singapore at $24. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | United States | $57 | 11 | 70.4% |
| 2 | Singapore | $24 | 6 | 29.6% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $46.
PRODUCT MIX
Unknown dominates at 31% of trade. Solution (28.2%) and Liquid are secondary formulations.
TOP BUYERS · 2/4 LOCKED IN
2 of 4 buyers source exclusively from this supplier — moderate lock-in, some buyers diversify.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Q SQUARED SOLUTIONS (Q… | United States | $57 | 2 sup. |
| IQVIA LABORATORIES ASI… | Singapore | $13 | 4 sup. |
| EUROFINS CENTRAL LAB P… | Singapore | $11 | ⚠ Locked |
| ICON LABORATORY SERVIC… | United States | $0 | ⚠ Locked |
#5
EXPORTER PROFILE #3 OF 4 — TRADE FLOW MAP
BRISTOL-MYERS SQUIBB INDIA PVT LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P3.3 United States absorbs $57 — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.
#8
EXPORTER PROFILE #4 OF 4
IQVIA RDS (INDIA) PVT LTD
Mumbai · India’s #8 serum supplier by USD · 2025-Q4
2025-Q4 USD
$25
0.3% market share
SHIPMENTS
5
avg $5/ship
COUNTRIES
2
destination markets
BUYERS
3
unique importers
BRANDED
20%
of shipments
DOSAGE FORMS
2
product types
TOP 2 DESTINATIONS
Singapore is the #1 market at $14 (55% of trade), followed by United States at $11. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Singapore | $14 | 3 | 54.6% |
| 2 | United States | $11 | 2 | 45.4% |
MONTHLY TREND
Nov peaked at $17. Oct was the weakest at $0.
PRODUCT MIX
Solution dominates at 55% of trade. Unknown (22.7%) and Other are secondary formulations.
TOP BUYERS · 2 BUYERS
Buyers are well-diversified across multiple Indian suppliers.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Q SQUARED SOLUTIONS (Q… | United States | $11 | 2 sup. |
| IQVIA LABORATORIES ASI… | Singapore | $8 | 4 sup. |
| Undisclosed buyer | Singapore | $6 | N/A |
#8
EXPORTER PROFILE #4 OF 4 — TRADE FLOW MAP
IQVIA RDS (INDIA) PVT LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P4.3 Singapore absorbs $14 — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
26 importers across 6 countries — who is buying Indian serum and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 24 importers together hold only 8.7% of total USD. 73% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian serum. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 Q SQUARED SOLUTIONS LLC is the #1 importer at $102.428 (1.2%) — top 24 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 24 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
73%
Single-source
19 buyers rely on exactly 1 Indian supplier
8%
Dual-source
2 buyers use 2 Indian suppliers
12%
Multi-source (3–4)
3 buyers diversified across 3–4
8%
Broad-source (5+)
2 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source serum from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
United States 5 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| Q SQUARED SOLUTIONS LLC | NOVARTIS HEALTHCARE … | $102.428 | $1.219 | Other |
| Q SQUARED SOLUTIONS LTD | NOVO NORDISK INDIA P… | $68.292 | $0.189 | Other |
| IQVIA LABORATORIES LLC | NOVO NORDISK INDIA P… | $22.773 | $3.795 | Other |
| SANOFI VACCINES, R & D… | SANOFI HEALTHCARE IN… | $10.000 | $0.016 | — |
| AZENTA LIFE SCIENCES | SYNGENE INTERNATIONA… | $9.898 | $4.949 | — |
Singapore 5 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ICON LABORATORIES SING… | NOVO NORDISK INDIA P… | $58.959 | $0.296 | Solution |
| PPD LABORATORIES CENTR… | PPD PHARMACEUTICAL D… | $13.976 | $0.998 | — |
| EUROFINS CENTRAL LAB P… | BRISTOL-MYERS SQUIBB… | $11.383 | $0.759 | — |
| PPD CENTRAL LAB | GLAXOSMITHKLINE PHAR… | $5.688 | $0.271 | — |
| Q SQUARED SOLUTIONS PT… | NOVARTIS HEALTHCARE … | $4.949 | $0.495 | Other |
United Kingdom 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| IQVIA LABORATORIES LTD | NOVO NORDISK INDIA P… | $39.857 | $2.098 | Other |
| LABCORP EARLY DEVELOPM… | NOVARTIS HEALTHCARE … | $5.695 | $0.356 | — |
| Q2 SQUARED SOLUTIONS LTD | GLAXOSMITHKLINE PHAR… | $5.695 | $1.898 | Solution |
Netherlands 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| EUROFINS CENTRAL LABOR… | NOVARTIS HEALTHCARE … | $5.688 | $0.474 | — |
§6.3 Price positioning — top 24 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | Q SQUARED SOLUTIONS … | United States | $102.428 | $6.000 | Budget |
| 2 | LABCORP DEVELOPMENT … | Singapore | $89.111 | $3.000 | Budget |
| 3 | QUINTILES LABORATORI… | United Kingdom | $85.363 | $6.000 | Budget |
| 4 | Q SQUARED SOLUTIONS … | United States | $68.305 | $6.000 | Budget |
| 5 | Q SQUARED SOLUTIONS … | United States | $68.292 | $6.000 | Budget |
| 6 | ICON LABORATORIES SI… | Singapore | $58.959 | $6.000 | Budget |
| 7 | IQVIA LABORATORIES A… | Singapore | $56.133 | $4.000 | Budget |
| 8 | IQVIA LABORATORIES LTD | United Kingdom | $39.857 | $6.000 | Budget |
| 9 | EUROFINS CENTRAL LAB | Singapore | $37.955 | $5.000 | Budget |
| 10 | MEDPACE SINGAPORE PT… | Singapore | $37.935 | $5.000 | Budget |
| 11 | IQVIA LABORATORIES LLC | United States | $22.773 | $6.000 | Budget |
| 12 | PPD LABORATORIES CEN… | Singapore | $13.976 | $7.000 | Budget |
| 13 | EUROFINS CENTRAL LAB… | Singapore | $11.383 | $6.000 | Budget |
| 14 | SANOFI VACCINES, R &… | United States | $10.000 | $10.000 | Budget |
| 15 | AZENTA LIFE SCIENCES | United States | $9.898 | $10.000 | Budget |
| 16 | LABCORP EARLY DEVELO… | United Kingdom | $5.695 | $6.000 | Budget |
| 17 | CHARLES RIVER LABORA… | United States | $5.695 | $6.000 | Budget |
| 18 | Q2 SQUARED SOLUTIONS… | United Kingdom | $5.695 | $6.000 | Budget |
| 19 | MOLECULAR MD | United States | $5.688 | $6.000 | Budget |
| 20 | PPD CENTRAL LAB | Singapore | $5.688 | $6.000 | Budget |
| 21 | EUROFINS CENTRAL LAB… | Netherlands | $5.688 | $6.000 | Budget |
| 22 | Q SQUARED SOLUTIONS … | Singapore | $4.949 | $5.000 | Budget |
| 23 | PPD GLOBAL CENTRAL L… | Singapore | $4.086 | $2.000 | Budget |
| 24 | ICON LABORATORY SERV… | United States | $0.0000 | $0.0000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 HIMEDIA LABORATORIES PVT LTD → Q SQUARED SOLUTIONS LLC is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian serum prices vary by supplier, country and dosage form
KEY TAKEAWAY
Serum prices span 12772× ($0.0019 → $24.24). The coefficient of variation is 1.81. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0019 | Lowest observed unit price |
| P5 | $0.059 | 5th percentile |
| P25 | $0.133 | 25th percentile (Q1) |
| Median | $0.474 | 50th percentile (Q2) |
| P75 | $1.42 | 75th percentile (Q3) |
| P95 | $5.69 | 95th percentile |
| Max | $24.24 | Highest observed unit price |
| Mean | $1.35 | Arithmetic average |
| CV | 181% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 TCG LIFESCIENCES PVT LTD prices at $24.24/unit vs market median $0.474.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. WORLDWIDE CLINICAL TRIALS Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. NOVO NORDISK INDIA Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. SANOFI HEALTHCARE INDIA Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. TCG LIFESCIENCES PVT Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | HIMEDIA LABORATO… | Nepal | — | 70 | $8K | $108.20 | Specialty / small-batch |
| Nov 2025 | TCG LIFESCIENCES… | China | Solution | 11 | $254.56 | $24.24 | Specialty / small-batch |
| Dec 2025 | NOVO NORDISK IND… | United States | — | 1 | $5.69 | $5.69 | Specialty / small-batch |
| Dec 2025 | NOVO NORDISK IND… | United Kingdom | — | 1 | $5.69 | $5.69 | Specialty / small-batch |
| Dec 2025 | NOVARTIS HEALTHC… | United Kingdom | Liquid | 1 | $5.69 | $5.69 | Specialty / small-batch |
| Dec 2025 | NOVO NORDISK IND… | United Kingdom | Liquid | 1 | $5.69 | $5.69 | Specialty / small-batch |
| Dec 2025 | NOVO NORDISK IND… | United Kingdom | Liquid | 1 | $5.69 | $5.69 | Specialty / small-batch |
| Dec 2025 | NOVARTIS HEALTHC… | United Kingdom | Liquid | 1 | $5.69 | $5.69 | Specialty / small-batch |
| Dec 2025 | NOVO NORDISK IND… | United States | Liquid | 1 | $5.69 | $5.69 | Specialty / small-batch |
| Dec 2025 | NOVO NORDISK IND… | United Kingdom | Liquid | 1 | $5.69 | $5.69 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | NOVO NORDISK IND… | Singapore | Solution | 30 | $0.057 | $0.0019 | Small sample / trial shipment |
| Dec 2025 | NOVARTIS HEALTHC… | Singapore | Solution | 24 | $0.057 | $0.0024 | Small sample / trial shipment |
| Dec 2025 | NOVARTIS HEALTHC… | Singapore | Other | 20 | $0.114 | $0.0057 | Small sample / trial shipment |
| Dec 2025 | SANOFI HEALTHCAR… | United States | — | 638 | $10.00 | $0.016 | Small sample / trial shipment |
| Nov 2025 | ASTRAZENECA PHAR… | Singapore | — | 28 | $1.34 | $0.048 | Small sample / trial shipment |
| Dec 2025 | ASTRAZENECA PHAR… | Singapore | — | 34 | $1.63 | $0.048 | Small sample / trial shipment |
| Nov 2025 | ASTRAZENECA PHAR… | Singapore | — | 33 | $1.69 | $0.051 | Small sample / trial shipment |
| Nov 2025 | PFIZER LTD | Singapore | biological substance | 31 | $1.83 | $0.059 | Small sample / trial shipment |
| Nov 2025 | PFIZER LTD | Singapore | — | 37 | $2.19 | $0.059 | Small sample / trial shipment |
| Nov 2025 | PFIZER LTD | Singapore | Other | 34 | $2.01 | $0.059 | Small sample / trial shipment |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship serum, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Serum leaves India through 3+ ports. The top 5 (MUMBAI AIR (SAHAR), DELHI AIR, BANGALORE AIR) handle 100.0% of total USD. AIR moves 98% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 MUMBAI AIR (SAHAR) handles $9K — top 3 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 KATHMANDU - TRIBHUVA is the #1 global destination port — top 8 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
AIR dominates at 98% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
AIR
$9K
99.7% of USD · 97.7% of ships
SEA
$23
0.3% of USD · 2.3% of ships
Fig 8.3 The dominant corridor is MUMBAI AIR (SAHAR) → Air → Asia ($8K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Netherlands is the most concentrated destination (HHI 10000, 1 suppliers). Singapore is the most competitive (HHI 1203).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Netherlands (HHI 10,000) is the most concentrated — Singapore (HHI 1,203) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 5 of 6 destination markets are concentrated (red zone). 1 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| Q SQUARED SOLUTIONS … | United States | NOVARTIS HEALTHC… | $102 | 18 | MEDIUM |
| Q SQUARED SOLUTIONS … | United States | NOVO NORDISK IND… | $68 | 12 | MEDIUM |
| ICON LABORATORIES SI… | Singapore | NOVO NORDISK IND… | $59 | 10 | MEDIUM |
| IQVIA LABORATORIES LTD | United Kingdom | NOVO NORDISK IND… | $40 | 7 | MEDIUM |
| IQVIA LABORATORIES LLC | United States | NOVO NORDISK IND… | $23 | 4 | MEDIUM |
| PPD LABORATORIES CEN… | Singapore | PPD PHARMACEUTIC… | $14 | 2 | MEDIUM |
| EUROFINS CENTRAL LAB… | Singapore | BRISTOL-MYERS SQ… | $11 | 2 | MEDIUM |
| SANOFI VACCINES, R &… | United States | SANOFI HEALTHCAR… | $10 | 1 | MEDIUM |
Conclusion: 18 buyers depend on exactly one Indian supplier, representing $381 in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|---|---|---|---|---|
| LABCORP DEVELOPMENT … | Singapore | 7 | $89 | ASTRAZENECA PH… | HIGH |
| QUINTILES LABORATORI… | United Kingdom | 3 | $85 | NOVARTIS HEALT… | MEDIUM |
| IQVIA LABORATORIES A… | Singapore | 4 | $56 | NOVARTIS HEALT… | MEDIUM |
| MEDPACE SINGAPORE PT… | Singapore | 4 | $38 | NOVARTIS HEALT… | MEDIUM |
Conclusion: 1 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| Nepal | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Singapore | Tier 2 (competitive) | 3–5 days (air) | $0.10–$1/unit | MEDIUM | Price + relationship |
| United States | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| China | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| United Kingdom | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Netherlands | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 5 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 4 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 4 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in United States | This Q | HIGH |
| A2 | Offer alternative to LABCORP DEVELOPMENT | This Q | HIGH |
| A3 | Audit Netherlands lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Nepal (1 suppliers) | This Q | HIGH |
| A6 | Enter China (1 suppliers) | This Q | MED |
| A8 | Build Singapore distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for Nepal tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 4 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Nepal | Asia | 1 | $8K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | China | Asia | 1 | $255 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | United Kingdom | Other | 4 | $142 | 0% | LOW | Low competition (4 suppliers), accessible market |
| 4 | Netherlands | Other | 1 | $6 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 171 2025-Q4 Serum shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/serum
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 171 2025-Q4 serum shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian serum shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
171
across all regions
TOTAL USD
$9K
2025-Q4 FOB value
UNITS
3.5K
tablets, capsules, etc.
SUPPLIERS
20
Indian exporters
BUYERS
26
global importers
COUNTRIES
6
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Asia is the largest region at $8K (94.8%), spanning 3 countries.
20 Indian suppliers shipped to 26 buyers across 6 countries — average shipment value $50.66.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
3 countries · 92 shipments · $8K · 18 Indian suppliers · 12 buyers
SHIPMENTS
92
USD
$8K
COUNTRIES
3
SUPPLIERS
18
BUYERS
12
HHI
8,522
concentrated
Top 3 destination countries in Asia
1
Nepal (92.2%)
$8K
2
Singapore (4.7%)
$381.99
3
China (3.1%)
$254.56
Top 18 Indian suppliers into Asia
1
HIMEDIA LABORATORIES PVT LTD
$8K
2
TCG LIFESCIENCES PVT LTD
$254.56
3
NOVO NORDISK INDIA PVT LTD
$92.96
4
NOVARTIS HEALTHCARE PVT LTD
$62.16
5
WORLDWIDE CLINICAL TRIALS INDIA PVT LTD
$34.96
6
ASTRAZENECA PHARMA INDIA LTD
$34.60
7
JOHNSON & JOHNSON PVT LTD
$24.11
8
KLINERA GLOBAL SERVICES
$23.96
9
BRISTOL-MYERS SQUIBB INDIA PVT LTD
$23.90
10
PPD PHARMACEUTICAL DEVELOPMENT INDIA PRIVATE LIMIT
$13.98
11
IQVIA RDS (INDIA) PVT LTD
$13.66
12
PFIZER LTD
$11.68
13
PAREXEL INTERNATIONAL CLINICAL RESEARCH PRIVATE LI
$9.98
14
MEDPACE CLINICAL RESEARCH INDIA PVT LTD
$9.98
15
NOVOTECH CLINICAL RESEARCH INDIA PVT LTD
$9.98
16
BAYER PHARMACEUTICALS PVT LTD
$6.25
17
GLAXOSMITHKLINE PHARMACEUTICALS LTD
$5.69
18
ELI LILLY AND COMPANY (INDIA ) PVT LTD
$4.13
Top 10 Asia importers
1
LABCORP DEVELOPMENT (ASIA) PTE LTD · Singapore
$89.11
2
ICON LABORATORIES SINGAPORE · Singapore
$58.96
3
IQVIA LABORATORIES ASIA PTE LTD · Singapore
$56.13
4
EUROFINS CENTRAL LAB · Singapore
$37.95
5
MEDPACE SINGAPORE PTE LTD · Singapore
$37.94
6
PPD LABORATORIES CENTRAL LAB SG · Singapore
$13.98
7
EUROFINS CENTRAL LAB PTE LTD · Singapore
$11.38
8
PPD CENTRAL LAB · Singapore
$5.69
9
Q SQUARED SOLUTIONS PTE LTD · Singapore
$4.95
10
PPD GLOBAL CENTRAL LABS · Singapore
$4.09
Top 7 dosage forms
1
Unknown
$8K
2
Solution
$434.49
3
Other
$74.10
4
Suspension
$9.98
5
Liquid
$4.99
6
Sample
$2.46
7
biological substance
$1.83
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 64 | $582.11 | $9.10 |
| Dec | 28 | $8K | $272.45 |
Shipment register · 92 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — HIMEDIA LABORATORIES PVT LTD · 1 shipments · $8K | |||||||||||
| 1 | Dec 2025 | UNLISTED BUYER | Nepal | 70 | NOS | $108.20 | $8K | MUMBAI AIR (SAHAR) | KATHMANDU - TRIBHUVA | AIR | |
| SUPPLIER #2 — TCG LIFESCIENCES PVT LTD · 1 shipments · $254.56 | |||||||||||
| 2 | Nov 2025 | UNKNOWN BUYER | China | Solution | 11 | GMS | $24.24 | $254.56 | MUMBAI AIR (SAHAR) | BEIJING | AIR |
| SUPPLIER #3 — NOVO NORDISK INDIA PVT LTD · 18 shipments · $92.96 | |||||||||||
| 3 | Nov 2025 | ICON LABORATORIES SINGAPORE | Singapore | Solution | 10 | NOS | $0.399 | $3.99 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 4 | Nov 2025 | ICON LABORATORIES SINGAPORE | Singapore | Solution | 10 | NOS | $0.499 | $4.99 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 5 | Nov 2025 | UNKNOWN BUYER | Singapore | Solution | 10 | NOS | $0.499 | $4.99 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 6 | Nov 2025 | ICON LABORATORIES SINGAPORE | Singapore | Solution | 14 | NOS | $0.357 | $4.99 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 7 | Nov 2025 | ICON LABORATORIES SINGAPORE | Singapore | Solution | 12 | NOS | $0.832 | $9.98 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 8 | Nov 2025 | UNKNOWN BUYER | Singapore | Suspension | 12 | NOS | $0.832 | $9.98 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 9 | Nov 2025 | ICON LABORATORIES SINGAPORE | Singapore | Liquid | 20 | NOS | $0.250 | $4.99 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 10 | Nov 2025 | ICON LABORATORIES SINGAPORE | Singapore | Other | 25 | NOS | $0.399 | $9.98 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 11 | Nov 2025 | IQVIA LABORATORIES ASIA PTE LTD | Singapore | Other | 10 | NOS | $0.569 | $5.69 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 12 | Nov 2025 | ICON LABORATORIES SINGAPORE | Singapore | Solution | 23 | NOS | $0.217 | $4.99 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 13 | Nov 2025 | IQVIA LABORATORIES ASIA PTE LTD | Singapore | Solution | 25 | NOS | $0.228 | $5.69 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 14 | Nov 2025 | ICON LABORATORIES SINGAPORE | Singapore | Solution | 40 | NOS | $0.250 | $9.98 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 15 | Nov 2025 | ICON LABORATORIES SINGAPORE | Singapore | Other | 15 | NOS | $0.333 | $4.99 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 16 | Dec 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | 33 | NOS | $0.069 | $2.29 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR | |
| 17 | Dec 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | 31 | NOS | $0.063 | $1.94 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR | |
| 18 | Dec 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | 28 | NOS | $0.068 | $1.91 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR | |
| 19 | Dec 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | 22 | NOS | $0.068 | $1.50 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR | |
| 20 | Dec 2025 | ICON LABORATORIES SINGAPORE | Singapore | Solution | 30 | NOS | $0.0019 | $0.057 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #4 — NOVARTIS HEALTHCARE PVT LTD · 14 shipments · $62.16 | |||||||||||
| 21 | Nov 2025 | Q SQUARED SOLUTIONS PTE LTD | Singapore | Other | 10 | NOS | $0.495 | $4.95 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 22 | Nov 2025 | IQVIA LABORATORIES ASIA PTE LTD | Singapore | Solution | 30 | NOS | $0.133 | $3.99 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 23 | Nov 2025 | MEDPACE SINGAPORE PTE LTD | Singapore | 10 | NOS | $0.499 | $4.99 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR | |
| 24 | Nov 2025 | UNKNOWN BUYER | Singapore | 23 | NOS | $0.174 | $3.99 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR | |
| 25 | Nov 2025 | UNKNOWN BUYER | Singapore | Solution | 14 | NOS | $0.357 | $4.99 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 26 | Nov 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | 10 | NOS | $0.998 | $9.98 | DELHI AIR | SINGAPORE | AIR | |
| 27 | Nov 2025 | MEDPACE SINGAPORE PTE LTD | Singapore | Solution | 13 | NOS | $0.307 | $3.99 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 28 | Nov 2025 | MEDPACE SINGAPORE PTE LTD | Singapore | Solution | 14 | NOS | $0.357 | $4.99 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 29 | Nov 2025 | IQVIA LABORATORIES ASIA PTE LTD | Singapore | Solution | 14 | NOS | $0.357 | $4.99 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 30 | Nov 2025 | IQVIA LABORATORIES ASIA PTE LTD | Singapore | Solution | 25 | NOS | $0.400 | $9.99 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 31 | Dec 2025 | IQVIA LABORATORIES ASIA PTE LTD | Singapore | Solution | 24 | NOS | $0.213 | $5.10 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 32 | Dec 2025 | IQVIA LABORATORIES ASIA PTE LTD | Singapore | Other | 20 | NOS | $0.0057 | $0.114 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 33 | Dec 2025 | IQVIA LABORATORIES ASIA PTE LTD | Singapore | Solution | 26 | NOS | $0.0009 | $0.023 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 34 | Dec 2025 | IQVIA LABORATORIES ASIA PTE LTD | Singapore | Solution | 24 | NOS | $0.0024 | $0.057 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #5 — WORLDWIDE CLINICAL TRIALS INDIA PVT LTD · 8 shipments · $34.96 | |||||||||||
| 35 | Nov 2025 | EUROFINS CENTRAL LAB | Singapore | Solution | 10 | NOS | $0.198 | $1.98 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 36 | Nov 2025 | EUROFINS CENTRAL LAB | Singapore | Other | 19 | NOS | $0.208 | $3.96 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 37 | Nov 2025 | EUROFINS CENTRAL LAB | Singapore | Solution | 20 | NOS | $0.250 | $4.99 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 38 | Nov 2025 | EUROFINS CENTRAL LAB | Singapore | Solution | 30 | NOS | $0.133 | $3.99 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 39 | Nov 2025 | UNKNOWN BUYER | Singapore | Other | 30 | NOS | $0.133 | $3.99 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 40 | Nov 2025 | UNKNOWN BUYER | Singapore | Solution | 10 | NOS | $0.299 | $2.99 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 41 | Nov 2025 | EUROFINS CENTRAL LAB | Singapore | Other | 20 | NOS | $0.499 | $9.99 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 42 | Dec 2025 | EUROFINS CENTRAL LAB | Singapore | Solution | 25 | NOS | $0.122 | $3.06 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #6 — ASTRAZENECA PHARMA INDIA LTD · 6 shipments · $34.60 | |||||||||||
| 43 | Nov 2025 | UNKNOWN BUYER | Singapore | 28 | NOS | $0.048 | $1.34 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR | |
| 44 | Nov 2025 | UNKNOWN BUYER | Singapore | 33 | NOS | $0.051 | $1.69 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR | |
| 45 | Nov 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | 10 | NOS | $0.998 | $9.98 | DELHI AIR | SINGAPORE | AIR | |
| 46 | Nov 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | 10 | NOS | $0.998 | $9.98 | DELHI AIR | SINGAPORE | AIR | |
| 47 | Nov 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | 10 | NOS | $0.998 | $9.98 | DELHI AIR | SINGAPORE | AIR | |
| 48 | Dec 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | 34 | NOS | $0.048 | $1.63 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR | |
| SUPPLIER #7 — JOHNSON & JOHNSON PVT LTD · 12 shipments · $24.11 | |||||||||||
| 49 | Nov 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | 34 | NOS | $0.074 | $2.51 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR | |
| 50 | Nov 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | 34 | NOS | $0.074 | $2.51 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR | |
| 51 | Nov 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | 15 | NOS | $0.114 | $1.71 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR | |
| 52 | Nov 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | Other | 26 | NOS | $0.085 | $2.22 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 53 | Nov 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | Sample | 26 | NOS | $0.094 | $2.46 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 54 | Dec 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | Solution | 26 | NOS | $0.085 | $2.22 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 55 | Dec 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | Solution | 29 | NOS | $0.068 | $1.98 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 56 | Dec 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | Solution | 21 | NOS | $0.080 | $1.67 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 57 | Dec 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | Solution | 25 | NOS | $0.077 | $1.94 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 58 | Dec 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | 29 | NOS | $0.063 | $1.82 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR | |
| 59 | Dec 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | 25 | NOS | $0.068 | $1.71 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR | |
| 60 | Dec 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | Solution | 20 | NOS | $0.068 | $1.37 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #8 — KLINERA GLOBAL SERVICES · 4 shipments · $23.96 | |||||||||||
| 61 | Nov 2025 | MEDPACE SINGAPORE PTE LTD | Singapore | Other | 15 | NOS | $0.666 | $9.98 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 62 | Nov 2025 | UNKNOWN BUYER | Singapore | Solution | 15 | NOS | $0.666 | $9.98 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 63 | Nov 2025 | MEDPACE SINGAPORE PTE LTD | Singapore | Solution | 15 | NOS | $0.266 | $3.99 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 64 | Dec 2025 | MEDPACE SINGAPORE PTE LTD | Singapore | Solution | 20 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #9 — BRISTOL-MYERS SQUIBB INDIA PVT LTD · 6 shipments · $23.90 | |||||||||||
| 65 | Nov 2025 | EUROFINS CENTRAL LAB PTE LTD | Singapore | 11 | NOS | $0.517 | $5.69 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR | |
| 66 | Nov 2025 | IQVIA LABORATORIES ASIA PTE LTD | Singapore | Solution | 32 | NOS | $0.178 | $5.69 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 67 | Nov 2025 | IQVIA LABORATORIES ASIA PTE LTD | Singapore | Other | 11 | NOS | $0.207 | $2.28 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 68 | Nov 2025 | IQVIA LABORATORIES ASIA PTE LTD | Singapore | Other | 15 | NOS | $0.152 | $2.28 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 69 | Nov 2025 | IQVIA LABORATORIES ASIA PTE LTD | Singapore | 14 | NOS | $0.163 | $2.28 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR | |
| 70 | Dec 2025 | EUROFINS CENTRAL LAB PTE LTD | Singapore | 4 | NOS | $1.42 | $5.69 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR | |
| SUPPLIER #10 — PPD PHARMACEUTICAL DEVELOPMENT INDIA PRIVATE LIMIT · 2 shipments · $13.98 | |||||||||||
| 71 | Nov 2025 | PPD LABORATORIES CENTRAL LAB SG | Singapore | 7 | NOS | $0.998 | $6.99 | DELHI AIR | SINGAPORE | AIR | |
| 72 | Nov 2025 | PPD LABORATORIES CENTRAL LAB SG | Singapore | 7 | NOS | $0.998 | $6.99 | DELHI AIR | SINGAPORE | AIR | |
| SUPPLIER #11 — IQVIA RDS (INDIA) PVT LTD · 3 shipments · $13.66 | |||||||||||
| 73 | Nov 2025 | UNKNOWN BUYER | Singapore | Solution | 20 | NOS | $0.284 | $5.69 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 74 | Dec 2025 | IQVIA LABORATORIES ASIA PTE LTD | Singapore | Solution | 28 | NOS | $0.081 | $2.28 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 75 | Dec 2025 | IQVIA LABORATORIES ASIA PTE LTD | Singapore | Solution | 16 | NOS | $0.356 | $5.69 | MUMBAI AIR (SAHAR) | SINGAPORE | SEA |
| SUPPLIER #12 — PFIZER LTD · 6 shipments · $11.68 | |||||||||||
| 76 | Nov 2025 | UNKNOWN BUYER | Singapore | 37 | NOS | $0.059 | $2.19 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR | |
| 77 | Nov 2025 | PPD GLOBAL CENTRAL LABS | Singapore | Solution | 33 | NOS | $0.068 | $2.25 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 78 | Nov 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | 25 | NOS | $0.068 | $1.71 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR | |
| 79 | Nov 2025 | PPD GLOBAL CENTRAL LABS | Singapore | biological substance | 31 | NOS | $0.059 | $1.83 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 80 | Nov 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | Other | 27 | NOS | $0.063 | $1.69 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 81 | Nov 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | Other | 34 | NOS | $0.059 | $2.01 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #13 — PAREXEL INTERNATIONAL CLINICAL RESEARCH PRIVATE LI · 2 shipments · $9.98 | |||||||||||
| 82 | Nov 2025 | MEDPACE SINGAPORE PTE LTD | Singapore | Other | 35 | NOS | $0.143 | $4.99 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 83 | Nov 2025 | UNKNOWN BUYER | Singapore | Solution | 35 | NOS | $0.143 | $4.99 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #14 — MEDPACE CLINICAL RESEARCH INDIA PVT LTD · 2 shipments · $9.98 | |||||||||||
| 84 | Nov 2025 | MEDPACE SINGAPORE PTE LTD | Singapore | Other | 10 | NOS | $0.499 | $4.99 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 85 | Nov 2025 | UNKNOWN BUYER | Singapore | Solution | 10 | NOS | $0.499 | $4.99 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #15 — NOVOTECH CLINICAL RESEARCH INDIA PVT LTD · 1 shipments · $9.98 | |||||||||||
| 86 | Nov 2025 | EUROFINS CENTRAL LAB | Singapore | Solution | 5 | NOS | $2.00 | $9.98 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #16 — BAYER PHARMACEUTICALS PVT LTD · 3 shipments · $6.25 | |||||||||||
| 87 | Dec 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | Solution | 35 | NOS | $0.068 | $2.39 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 88 | Dec 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | Solution | 27 | NOS | $0.059 | $1.60 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 89 | Dec 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | Solution | 33 | NOS | $0.068 | $2.26 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #17 — GLAXOSMITHKLINE PHARMACEUTICALS LTD · 1 shipments · $5.69 | |||||||||||
| 90 | Nov 2025 | PPD CENTRAL LAB | Singapore | 21 | NOS | $0.271 | $5.69 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR | |
| SUPPLIER #18 — ELI LILLY AND COMPANY (INDIA ) PVT LTD · 2 shipments · $4.13 | |||||||||||
| 91 | Dec 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | Solution | 29 | NOS | $0.068 | $1.98 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 92 | Dec 2025 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | Solution | 35 | NOS | $0.062 | $2.15 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
2 countries · 26 shipments · $147.99 · 4 Indian suppliers · 6 buyers
SHIPMENTS
26
USD
$147.99
COUNTRIES
2
SUPPLIERS
4
BUYERS
6
HHI
4,290
concentrated
Top 2 destination countries in Europe
1
United Kingdom (96.2%)
$142.30
2
Netherlands (3.8%)
$5.69
Top 4 Indian suppliers into Europe
1
NOVO NORDISK INDIA PVT LTD
$68.31
2
NOVARTIS HEALTHCARE PVT LTD
$68.29
3
GLAXOSMITHKLINE PHARMACEUTICALS LTD
$5.69
4
ELI LILLY AND COMPANY (INDIA ) PVT LTD
$5.69
Top 5 Europe importers
1
QUINTILES LABORATORIES EUROPE (QLE · United Kingdom
$85.36
2
IQVIA LABORATORIES LTD · United Kingdom
$39.86
3
LABCORP EARLY DEVELOPMENT LABORATOR · United Kingdom
$5.69
4
Q2 SQUARED SOLUTIONS LTD · United Kingdom
$5.69
5
EUROFINS CENTRAL LABORATORY · Netherlands
$5.69
Top 4 dosage forms
1
Unknown
$45.53
2
Other
$39.82
3
Solution
$34.16
4
Liquid
$28.47
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 12 | $68.26 | $5.69 |
| Dec | 14 | $79.73 | $5.69 |
Shipment register · 26 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — NOVO NORDISK INDIA PVT LTD · 12 shipments · $68.31 | |||||||||||
| 1 | Nov 2025 | QUINTILES LABORATORIES EUROPE (QLE | United Kingdom | Other | 4 | NOS | $1.42 | $5.69 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | AIR |
| 2 | Nov 2025 | QUINTILES LABORATORIES EUROPE (QLE | United Kingdom | Other | 4 | NOS | $1.42 | $5.69 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | AIR |
| 3 | Nov 2025 | IQVIA LABORATORIES LTD | United Kingdom | Other | 2 | NOS | $2.84 | $5.69 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | AIR |
| 4 | Nov 2025 | QUINTILES LABORATORIES EUROPE (QLE | United Kingdom | Solution | 6 | NOS | $0.948 | $5.69 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | AIR |
| 5 | Dec 2025 | QUINTILES LABORATORIES EUROPE (QLE | United Kingdom | 3 | NOS | $1.90 | $5.69 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | AIR | |
| 6 | Dec 2025 | QUINTILES LABORATORIES EUROPE (QLE | United Kingdom | 2 | NOS | $2.85 | $5.69 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | AIR | |
| 7 | Dec 2025 | IQVIA LABORATORIES LTD | United Kingdom | 1 | NOS | $5.69 | $5.69 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | AIR | |
| 8 | Dec 2025 | IQVIA LABORATORIES LTD | United Kingdom | Liquid | 1 | NOS | $5.69 | $5.69 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | SEA |
| 9 | Dec 2025 | IQVIA LABORATORIES LTD | United Kingdom | Liquid | 1 | NOS | $5.69 | $5.69 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | AIR |
| 10 | Dec 2025 | IQVIA LABORATORIES LTD | United Kingdom | Liquid | 1 | NOS | $5.69 | $5.69 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | SEA |
| 11 | Dec 2025 | IQVIA LABORATORIES LTD | United Kingdom | Solution | 10 | NOS | $0.569 | $5.69 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | AIR |
| 12 | Dec 2025 | IQVIA LABORATORIES LTD | United Kingdom | Solution | 3 | NOS | $1.90 | $5.69 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | AIR |
| SUPPLIER #2 — NOVARTIS HEALTHCARE PVT LTD · 12 shipments · $68.29 | |||||||||||
| 13 | Nov 2025 | QUINTILES LABORATORIES EUROPE (QLE | United Kingdom | Other | 24 | NOS | $0.237 | $5.69 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | AIR |
| 14 | Nov 2025 | QUINTILES LABORATORIES EUROPE (QLE | United Kingdom | Other | 4 | NOS | $1.42 | $5.69 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | AIR |
| 15 | Nov 2025 | QUINTILES LABORATORIES EUROPE (QLE | United Kingdom | 12 | NOS | $0.474 | $5.69 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | AIR | |
| 16 | Nov 2025 | QUINTILES LABORATORIES EUROPE (QLE | United Kingdom | 4 | NOS | $1.42 | $5.69 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | AIR | |
| 17 | Nov 2025 | EUROFINS CENTRAL LABORATORY | Netherlands | 12 | NOS | $0.474 | $5.69 | MUMBAI AIR (SAHAR) | AMSTERDAM, SCHIPHOL | AIR | |
| 18 | Nov 2025 | UNKNOWN BUYER | United Kingdom | 1 | NOS | $5.69 | $5.69 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | AIR | |
| 19 | Nov 2025 | QUINTILES LABORATORIES EUROPE (QLE | United Kingdom | Other | 2 | NOS | $2.84 | $5.69 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | AIR |
| 20 | Dec 2025 | LABCORP EARLY DEVELOPMENT LABORATOR | United Kingdom | 16 | NOS | $0.356 | $5.69 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | AIR | |
| 21 | Dec 2025 | QUINTILES LABORATORIES EUROPE (QLE | United Kingdom | Liquid | 1 | NOS | $5.69 | $5.69 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | AIR |
| 22 | Dec 2025 | QUINTILES LABORATORIES EUROPE (QLE | United Kingdom | Liquid | 1 | NOS | $5.69 | $5.69 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | AIR |
| 23 | Dec 2025 | QUINTILES LABORATORIES EUROPE (QLE | United Kingdom | Solution | 1 | NOS | $5.69 | $5.69 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | AIR |
| 24 | Dec 2025 | QUINTILES LABORATORIES EUROPE (QLE | United Kingdom | Solution | 1 | NOS | $5.69 | $5.69 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | AIR |
| SUPPLIER #3 — GLAXOSMITHKLINE PHARMACEUTICALS LTD · 1 shipments · $5.69 | |||||||||||
| 25 | Dec 2025 | Q2 SQUARED SOLUTIONS LTD | United Kingdom | Solution | 3 | NOS | $1.90 | $5.69 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | AIR |
| SUPPLIER #4 — ELI LILLY AND COMPANY (INDIA ) PVT LTD · 1 shipments · $5.69 | |||||||||||
| 26 | Nov 2025 | QUINTILES LABORATORIES EUROPE (QLE | United Kingdom | Other | 12 | NOS | $0.474 | $5.69 | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
1 countries · 53 shipments · $304.45 · 6 Indian suppliers · 10 buyers
SHIPMENTS
53
USD
$304.45
COUNTRIES
1
SUPPLIERS
6
BUYERS
10
HHI
2,914
concentrated
Top 1 destination countries in Americas
1
United States (100.0%)
$304.45
Top 6 Indian suppliers into Americas
1
NOVARTIS HEALTHCARE PVT LTD
$113.80
2
NOVO NORDISK INDIA PVT LTD
$102.45
3
BRISTOL-MYERS SQUIBB INDIA PVT LTD
$56.93
4
IQVIA RDS (INDIA) PVT LTD
$11.38
5
SANOFI HEALTHCARE INDIA PVT LTD
$10.00
6
SYNGENE INTERNATIONAL LTD
$9.90
Top 9 Americas importers
1
Q SQUARED SOLUTIONS LLC · United States
$102.43
2
Q SQUARED SOLUTIONS (QVAL) · United States
$68.30
3
Q SQUARED SOLUTIONS LTD · United States
$68.29
4
IQVIA LABORATORIES LLC · United States
$22.77
5
SANOFI VACCINES, R & D GLOBAL LABOR · United States
$10.00
6
AZENTA LIFE SCIENCES · United States
$9.90
7
CHARLES RIVER LABORATORIES INC · United States
$5.69
8
MOLECULAR MD · United States
$5.69
9
ICON LABORATORY SERVICES INC · United States
$0.0000
Top 6 dosage forms
1
Unknown
$110.95
2
Solution
$79.69
3
Other
$62.57
4
Liquid
$28.47
5
Serum
$11.39
6
biological_substance
$11.38
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 29 | $169.17 | $5.83 |
| Dec | 24 | $135.28 | $5.64 |
Shipment register · 53 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — NOVARTIS HEALTHCARE PVT LTD · 20 shipments · $113.80 | |||||||||||
| 1 | Nov 2025 | Q SQUARED SOLUTIONS LLC | United States | Other | 2 | NOS | $2.84 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 2 | Nov 2025 | Q SQUARED SOLUTIONS LLC | United States | Other | 10 | NOS | $0.569 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 3 | Nov 2025 | MOLECULAR MD | United States | 60 | NOS | $0.095 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR | |
| 4 | Nov 2025 | Q SQUARED SOLUTIONS LLC | United States | 1 | NOS | $5.69 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR | |
| 5 | Nov 2025 | Q SQUARED SOLUTIONS LLC | United States | 8 | NOS | $0.711 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR | |
| 6 | Nov 2025 | Q SQUARED SOLUTIONS LLC | United States | 8 | NOS | $0.711 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR | |
| 7 | Nov 2025 | Q SQUARED SOLUTIONS LLC | United States | biological_substance | 6 | NOS | $0.948 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 8 | Nov 2025 | UNKNOWN BUYER | United States | biological_substance | 6 | NOS | $0.948 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 9 | Nov 2025 | Q SQUARED SOLUTIONS LLC | United States | 5 | NOS | $1.14 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR | |
| 10 | Nov 2025 | Q SQUARED SOLUTIONS LLC | United States | 2 | NOS | $2.84 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR | |
| 11 | Nov 2025 | Q SQUARED SOLUTIONS LLC | United States | Other | 4 | NOS | $1.42 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 12 | Nov 2025 | Q SQUARED SOLUTIONS LLC | United States | Other | 10 | NOS | $0.569 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 13 | Nov 2025 | Q SQUARED SOLUTIONS LLC | United States | Solution | 5 | NOS | $1.14 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 14 | Nov 2025 | Q SQUARED SOLUTIONS LLC | United States | Solution | 4 | NOS | $1.42 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 15 | Dec 2025 | Q SQUARED SOLUTIONS LLC | United States | 3 | NOS | $1.90 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR | |
| 16 | Dec 2025 | Q SQUARED SOLUTIONS LLC | United States | Liquid | 5 | NOS | $1.14 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 17 | Dec 2025 | Q SQUARED SOLUTIONS LLC | United States | Solution | 5 | NOS | $1.14 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 18 | Dec 2025 | Q SQUARED SOLUTIONS LLC | United States | Solution | 4 | NOS | $1.42 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 19 | Dec 2025 | Q SQUARED SOLUTIONS LLC | United States | Solution | 1 | NOS | $5.69 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 20 | Dec 2025 | Q SQUARED SOLUTIONS LLC | United States | Solution | 1 | NOS | $5.69 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| SUPPLIER #2 — NOVO NORDISK INDIA PVT LTD · 18 shipments · $102.45 | |||||||||||
| 21 | Nov 2025 | Q SQUARED SOLUTIONS LTD | United States | Other | 25 | NOS | $0.228 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 22 | Nov 2025 | Q SQUARED SOLUTIONS LTD | United States | Other | 1 | NOS | $5.69 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 23 | Nov 2025 | UNKNOWN BUYER | United States | 1 | NOS | $5.69 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR | |
| 24 | Nov 2025 | Q SQUARED SOLUTIONS LTD | United States | 90 | NOS | $0.063 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR | |
| 25 | Nov 2025 | Q SQUARED SOLUTIONS LTD | United States | Other | 18 | NOS | $0.316 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 26 | Nov 2025 | IQVIA LABORATORIES LLC | United States | Other | 2 | NOS | $2.84 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 27 | Nov 2025 | Q SQUARED SOLUTIONS LTD | United States | Other | 50 | NOS | $0.114 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 28 | Nov 2025 | Q SQUARED SOLUTIONS LTD | United States | Solution | 2 | NOS | $2.84 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 29 | Nov 2025 | Q SQUARED SOLUTIONS LTD | United States | Solution | 42 | NOS | $0.135 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 30 | Dec 2025 | Q SQUARED SOLUTIONS LTD | United States | 21 | NOS | $0.271 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR | |
| 31 | Dec 2025 | IQVIA LABORATORIES LLC | United States | 1 | NOS | $5.69 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR | |
| 32 | Dec 2025 | CHARLES RIVER LABORATORIES INC | United States | 22 | NOS | $0.259 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR | |
| 33 | Dec 2025 | Q SQUARED SOLUTIONS LTD | United States | 9 | NOS | $0.633 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR | |
| 34 | Dec 2025 | Q SQUARED SOLUTIONS LTD | United States | Liquid | 20 | NOS | $0.285 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 35 | Dec 2025 | IQVIA LABORATORIES LLC | United States | Liquid | 1 | NOS | $5.69 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | SEA |
| 36 | Dec 2025 | IQVIA LABORATORIES LLC | United States | Solution | 2 | NOS | $2.85 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 37 | Dec 2025 | Q SQUARED SOLUTIONS LTD | United States | Solution | 3 | NOS | $1.90 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 38 | Dec 2025 | Q SQUARED SOLUTIONS LTD | United States | Solution | 80 | NOS | $0.071 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| SUPPLIER #3 — BRISTOL-MYERS SQUIBB INDIA PVT LTD · 11 shipments · $56.93 | |||||||||||
| 39 | Nov 2025 | Q SQUARED SOLUTIONS (QVAL) | United States | Other | 6 | NOS | $0.948 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 40 | Nov 2025 | Q SQUARED SOLUTIONS (QVAL) | United States | 5 | NOS | $1.14 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR | |
| 41 | Nov 2025 | Q SQUARED SOLUTIONS (QVAL) | United States | Solution | 4 | NOS | $1.42 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 42 | Dec 2025 | Q SQUARED SOLUTIONS (QVAL) | United States | 2 | NOS | $2.85 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR | |
| 43 | Dec 2025 | Q SQUARED SOLUTIONS (QVAL) | United States | Liquid | 2 | NOS | $2.85 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 44 | Dec 2025 | Q SQUARED SOLUTIONS (QVAL) | United States | Liquid | 2 | NOS | $2.85 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 45 | Dec 2025 | ICON LABORATORY SERVICES INC | United States | Solution | 137 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 46 | Dec 2025 | Q SQUARED SOLUTIONS (QVAL) | United States | Solution | 3 | NOS | $1.90 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 47 | Dec 2025 | Q SQUARED SOLUTIONS (QVAL) | United States | Solution | 2 | NOS | $2.85 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 48 | Dec 2025 | Q SQUARED SOLUTIONS (QVAL) | United States | Serum | 2 | NOS | $2.85 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| 49 | Dec 2025 | Q SQUARED SOLUTIONS (QVAL) | United States | Serum | 16 | NOS | $0.356 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| SUPPLIER #4 — IQVIA RDS (INDIA) PVT LTD · 2 shipments · $11.38 | |||||||||||
| 50 | Nov 2025 | Q SQUARED SOLUTIONS (QVAL) | United States | 10 | NOS | $0.569 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR | |
| 51 | Nov 2025 | Q SQUARED SOLUTIONS (QVAL) | United States | Other | 10 | NOS | $0.569 | $5.69 | MUMBAI AIR (SAHAR) | LOS ANGELES | AIR |
| SUPPLIER #5 — SANOFI HEALTHCARE INDIA PVT LTD · 1 shipments · $10.00 | |||||||||||
| 52 | Dec 2025 | SANOFI VACCINES, R & D GLOBAL LABOR | United States | 638 | NOS | $0.016 | $10.00 | MUMBAI AIR (SAHAR) | NEW YORK - JOHN F. K | AIR | |
| SUPPLIER #6 — SYNGENE INTERNATIONAL LTD · 1 shipments · $9.90 | |||||||||||
| 53 | Nov 2025 | AZENTA LIFE SCIENCES | United States | 2 | NOS | $4.95 | $9.90 | BANGALORE AIR | INDIANAPOLIS, IN | AIR | |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 20 Indian serum exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped serum in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | HIMEDIA LABORATORIES PVT LTD | THANE | 1 | $8K | Asia | |
| 2 | NOVO NORDISK INDIA PVT LTD | BANGALORE | 48 | $263.72 | Other, Solution, Suspension | Europe, Americas |
| 3 | TCG LIFESCIENCES PVT LTD | SALTLAKE ELECTRONICS COMPLEX | 1 | $254.56 | Solution | Asia |
| 4 | NOVARTIS HEALTHCARE PVT LTD | MUMBAI | 46 | $244.26 | Other, Solution, biological_substance | Europe, Americas |
| 5 | BRISTOL-MYERS SQUIBB INDIA PVT LTD | MUMBAI | 17 | $80.83 | Other, Solution, Liquid | Americas, Asia |
| 6 | WORLDWIDE CLINICAL TRIALS INDIA PVT LTD | CHEMBUR | 8 | $34.96 | Solution, Other | Asia |
| 7 | ASTRAZENECA PHARMA INDIA LTD | OUTERRINGROAD | 6 | $34.60 | Asia | |
| 8 | IQVIA RDS (INDIA) PVT LTD | Mumbai | 5 | $25.04 | Solution, Other | Americas, Asia |
| 9 | JOHNSON & JOHNSON PVT LTD | MUMBAI | 12 | $24.11 | Other, Sample, Solution | Asia |
| 10 | KLINERA GLOBAL SERVICES | MUMBAI | 4 | $23.96 | Other, Solution | Asia |
| 11 | PPD PHARMACEUTICAL DEVELOPMENT INDIA PRIVATE LIMIT | MUMBAI | 2 | $13.98 | Asia | |
| 12 | PFIZER LTD | G BLOCK | 6 | $11.68 | Solution, biological substance, Other | Asia |
| 13 | GLAXOSMITHKLINE PHARMACEUTICALS LTD | MUMBAI | 2 | $11.38 | Solution | Asia, Europe |
| 14 | SANOFI HEALTHCARE INDIA PVT LTD | POWAI - MUMBAI CITY | 1 | $10.00 | Americas | |
| 15 | PAREXEL INTERNATIONAL CLINICAL RESEARCH PRIVATE LI | BANGALORE | 2 | $9.98 | Other, Solution | Asia |
| 16 | MEDPACE CLINICAL RESEARCH INDIA PVT LTD | Navi Mumbai | 2 | $9.98 | Other, Solution | Asia |
| 17 | NOVOTECH CLINICAL RESEARCH INDIA PVT LTD | BENGALURU | 1 | $9.98 | Solution | Asia |
| 18 | SYNGENE INTERNATIONAL LTD | ICS CITY HOSUR ROAD BANGALORE | 1 | $9.90 | Americas | |
| 19 | ELI LILLY AND COMPANY (INDIA ) PVT LTD | GURGAON | 3 | $9.82 | Other, Solution | Europe, Asia |
| 20 | BAYER PHARMACEUTICALS PVT LTD | THANE WEST | 3 | $6.25 | Solution | Asia |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 24 global serum importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian serum in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | Q SQUARED SOLUTIONS LLC | United States | 18 | $102.43 | NOVARTIS HEALTHCARE … | Other, biological_substance, Solution |
| 2 | LABCORP DEVELOPMENT (ASIA) PTE LTD | Singapore | 29 | $89.11 | ASTRAZENECA PHARMA I… | Other, Sample, Solution |
| 3 | QUINTILES LABORATORIES EUROPE (QLE | United Kingdom | 15 | $85.36 | NOVARTIS HEALTHCARE … | Other, Solution, Liquid |
| 4 | Q SQUARED SOLUTIONS (QVAL) | United States | 12 | $68.30 | BRISTOL-MYERS SQUIBB… | Other, Solution, Liquid |
| 5 | Q SQUARED SOLUTIONS LTD | United States | 12 | $68.29 | NOVO NORDISK INDIA P… | Other, Solution, Liquid |
| 6 | ICON LABORATORIES SINGAPORE | Singapore | 10 | $58.96 | NOVO NORDISK INDIA P… | Solution, Liquid, Other |
| 7 | IQVIA LABORATORIES ASIA PTE LTD | Singapore | 15 | $56.13 | NOVARTIS HEALTHCARE … | Solution, Other |
| 8 | IQVIA LABORATORIES LTD | United Kingdom | 7 | $39.86 | NOVO NORDISK INDIA P… | Other, Liquid, Solution |
| 9 | EUROFINS CENTRAL LAB | Singapore | 7 | $37.95 | WORLDWIDE CLINICAL T… | Solution, Other |
| 10 | MEDPACE SINGAPORE PTE LTD | Singapore | 8 | $37.94 | NOVARTIS HEALTHCARE … | Other, Solution |
| 11 | IQVIA LABORATORIES LLC | United States | 4 | $22.77 | NOVO NORDISK INDIA P… | Other, Liquid, Solution |
| 12 | PPD LABORATORIES CENTRAL LAB SG | Singapore | 2 | $13.98 | PPD PHARMACEUTICAL D… | |
| 13 | EUROFINS CENTRAL LAB PTE LTD | Singapore | 2 | $11.38 | BRISTOL-MYERS SQUIBB… | |
| 14 | SANOFI VACCINES, R & D GLOBAL LABOR | United States | 1 | $10.00 | SANOFI HEALTHCARE IN… | |
| 15 | AZENTA LIFE SCIENCES | United States | 1 | $9.90 | SYNGENE INTERNATIONA… | |
| 16 | LABCORP EARLY DEVELOPMENT LABORATOR | United Kingdom | 1 | $5.69 | NOVARTIS HEALTHCARE … | |
| 17 | CHARLES RIVER LABORATORIES INC | United States | 1 | $5.69 | NOVO NORDISK INDIA P… | |
| 18 | Q2 SQUARED SOLUTIONS LTD | United Kingdom | 1 | $5.69 | GLAXOSMITHKLINE PHAR… | Solution |
| 19 | MOLECULAR MD | United States | 1 | $5.69 | NOVARTIS HEALTHCARE … | |
| 20 | PPD CENTRAL LAB | Singapore | 1 | $5.69 | GLAXOSMITHKLINE PHAR… | |
| 21 | EUROFINS CENTRAL LABORATORY | Netherlands | 1 | $5.69 | NOVARTIS HEALTHCARE … | |
| 22 | Q SQUARED SOLUTIONS PTE LTD | Singapore | 1 | $4.95 | NOVARTIS HEALTHCARE … | Other |
| 23 | PPD GLOBAL CENTRAL LABS | Singapore | 2 | $4.09 | PFIZER LTD | Solution, biological substance |
| 24 | ICON LABORATORY SERVICES INC | United States | 1 | $0.0000 | BRISTOL-MYERS SQUIBB… | Solution |
This report covers 171 2025-Q4 Serum shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/serum
Talk to our trade analyst
Need a custom serum report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/serum
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Serum product page
Live data, supplier directory, price trends, and trade route analysis